Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Chemring backs annual outlook as half-year profit jumps on new orders

Published 03/06/2020, 07:37
Updated 03/06/2020, 08:15
CHG
-

(Reuters) - British defence contractor Chemring Group (L:CHG) on Wednesday stood by its annual targets and posted a jump in half-year profit, as it won new orders from the United States despite the coronavirus crisis.

Chemring said its order book was strong and about 95% of the expected revenue for the second-half of the year has been delivered to date, after its underlying profit before tax rose to 24.2 million pounds in the six months to April 30, from 9.9 million pounds a year earlier.

"H1 performance was ahead of our expectations reflecting strong performance in both segments and some positive timing differences," the company said.

Order intake rose 1% to 250 million pounds in the first half, leaving the company with an order book of 504 million pounds.

The company said it has received additional delivery orders worth $32 million for the next phase of the Husky Mounted Detection System IDIQ from the United States, besides winning a U.S. Navy contract in May, which is expected to be worth up to $100 million over 5-10 years.

Chemring, which employs about 2,500 people worldwide, said all its businesses have remained open despite COVID-19 challenges.

The London-listed company also reduced its debt pile by 30% to 60.6 million pounds as of April-end and raised interim dividend by 8% to 1.3 pence per share.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.